Article information
Article
These are the options to access the full texts of the publication Revista Española de Anestesiología y Reanimación (English Edition)
Subscriber
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
G. Szappanyos, M. Gemperle, K. Rifat.
Selective indications for ketamine anaesthesia.
Proc R Soc Med, 64 (1971), pp. 1156-1159
[2]
C.L. Errando.
Tesis doctoral. Evaluacion clinica y experimental de una técnica de anestesia intravenosa total: ketamina, midazolam, vecuronio. Facultad de Medicina y Odontología. Departamento de Cirugía (Anestesiología).
Facultad de Medicina de Valencia, (1996),
[3]
G. Corssen, E. Domino.
Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581.
Anesth Analg, 45 (1966), pp. 29
[4]
J.P. Jantzen, D. Hilley, A.H. Giesecke.
Pharmacokinetics and pharmacodynamics of ketamine following intravenous, intramuscular and rectal administration to conditioned foxhounds.
Status of ketamine in anesthesiology, pp. 279-284
[5]
W.L. Way, A.J. Trevor, P.F. White.
Pharmacology of the ketamine enantiomorphs.
Status of ketamine in anesthesiology, pp. 101-107
[6]
A. Villalonga, L. Bento, T. Lingombele, J.P. Talaguma Bakwa.
Anestesia y cirugía en condiciones muy precarias. Casos clínicos.
Rev Esp Anestesiol Reanim, (2021),
[7]
C.L. Errando.
Ketamina ¿algo nuevo acerca de este fármaco?.
Rev Esp Anestesiol Reanim, 49 (2002), pp. 389-390
[8]
V. Orhurhu, M.S. Orhurhu, A. Bhatia, S.P. Cohen.
Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials.
Anesth Analg, 129 (2019), pp. 241-254
[9]
M. Cortiñas-Sáenz, M. Alonso-Menoyo, C.L. Errando-Oyonarte, L. Alférez-García, M. Carricondo-Martínez.
Efecto antidepresivo de dosis subanestésicas de ketamina en el postoperatorio de una paciente con depresión no controlada.
Rev Esp Anestesiol Reanim, 60 (2013), pp. 110-113
[10]
R.S. Duman.
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.
Dialogues Clin Neurosci, 16 (2014), pp. 11-27
[11]
United Nations. Economic and Social Council. E/CN.7/2015/7/Add.1. Commission on Narcotic Drugs. Fifty-eighth session. Vienna, 9–17 March 2015. Item 6 (b) of the provisional agenda. Implementation of the international drug control treaties: changes in the scope of control of substances. II. Consideration of a notification from China concerning the proposed recommendation for international control of ketamine under the Convention on Psychotropic Substances of 1971.
[12]
United Nations. Economic and Social Council. E/CN.7/2015/7. Commission on Narcotic Drugs. Fifty-eighth session. Vienna, 9-17 March 2015. Item 6 (b) of the provisional agenda. Implementation of the international drug control treaties: changes in the scope of control of substances. II. Consideration of a notification from China concerning the proposed recommendation for international control of ketamine under the Convention on Psychotropic Substances of 1971.
[13]
M.E. Durieux.
The goose and the gander.
Anesth Analg, 122 (2016), pp. 583-585
[14]
J.W. Nickerson, A. Attaran.
The Commission on Narcotic Drugs’ attempt to restrict ketamine.
Lancet, 385 (2015), pp. e19
[15]
G.P. Joshi, B. Onajin-Obembe.
The role of ketamine in low- and middle-income countries: what would happen if ketamine becomes a scheduled drug?.
Anesth Analg, 122 (2016), pp. 908-910
[16]
J.E. Cottrell, J. Hartung.
Ketamine versus Special K: a double-edged sword.
Anesth Analg, 122 (2016), pp. 586
